Frontlight ResearchEarly access
Fabry disease trials in Germany
3 of 7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 14 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in GermanyA Study to Learn How Well Lucerastat Works and How Safe it is in Untreated Adult Male Participants With Fabry Disease
- Where
- Berlin, Wuerzburg
- Age
- 18 years to 60 years
- People
- 16 worldwide
- Run by
- Idorsia Pharmaceuticals Ltd.
See details and how to joinNCT07778667 · EU 2026-525207-27-00 - Phase 3Taking peopleA Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants
- Where
- Münster
- Age
- 2 years to 11 years
- People
- 8 worldwide
- Run by
- Amicus Therapeutics
See details and how to joinNCT06904261 - Phase 3Not yet taking people in GermanyAn Open-label Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of 12-month Treatment with Migalastat in Pediatric Subjects (aged 2 to < 12 years) with Fabry Disease and Amenable GLA Variants
- Where
- Muenster
- Age
- Up to 17 years
- People
- 3 worldwide
- Run by
- Amicus Therapeutics Inc.
See details and how to join2025-521244-38-00